Trump’s 100% Generic Drug Duty Threatens US Low-Cost Supply

(Bloomberg) -- Generic drug manufacturers will have two years to move production to the US or face a 100% import duty from August 2028, President Donald Trump said, threatening the supply of low-cost medicines that millions of Americans rely on.

Raccontata daeluniverso.combiopharmadive.comtimesofindia.indiatimes.comeconomictimes.indiatimes.comhindustantimes.comfrance24.combenzinga.commalaymail.comnewsbytesapp.comlemonde.frswissinfo.chthehindubusinessline.com+1 altre